Keros Therapeutics, Inc. insider trading activity

Understanding Insider Activity at Keros Therapeutics, Inc.

Welcome to our dedicated page for Keros Therapeutics, Inc. (Nasdaq: KROS) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Keros Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Keros Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for KROS
TickerTime & DateFilingLink
KROS09:06:51 PM, 08/15/2024
GORDON CARL L sold 250000 shares of Keros Therapeutics, Inc. (KROS) for ~$11002500
Filing
KROS09:01:28 PM, 08/15/2024
ORBIMED ADVISORS LLC sold 250000 shares of Keros Therapeutics, Inc. (KROS) for ~$11002500
Filing
KROS09:43:46 PM, 01/08/2024
Regnante Keith(Chief Financial Officer) sold 40000 shares of Keros Therapeutics, Inc. (KROS) for ~$1811600
Filing
KROS08:13:40 PM, 06/12/2023
Regnante Keith(Chief Financial Officer) sold 40000 shares of Keros Therapeutics, Inc. (KROS) for ~$1864236
Filing
KROS09:32:18 PM, 01/20/2023
Knowles Julius purchased 1191 shares of Keros Therapeutics, Inc. (KROS) for ~$24987
Filing